Are cytokines responsible for the asthmatic state of the airways?

Monaldi Archives for Chest Disease

Volumn 51, Issue 3, 1996, Pages 223-227

  Kips, J C ^a   Pauwels, R A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Asthma; Cytokines; Interleukin 12; Interleukin 4; Interleukin 5; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMA; ASTHMATIC STATE; HELPER CELL; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

EID: 0030035724     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hamid Q, Azzawi M, Sun Ying, et al. - Expression of mRNA for interleukin-5 in mucosal biopsies from asthma. J Clin Invest 1991; 87: 1561-1566.
2. Bradding P, Roberts JA, Britten KM, et al. - Interleukin-4, -5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471-480.
3. Sun Ying, Robinson DS, Varney V, et al. - TNF-alpha nRNA expression in allergic inflammation. Clin Exp Allergy 1991; 21: 745-750.
4. Borish L, Mascall JJ, Dishuck J, Beam WR, Martin JR, Rosenwasser LJ. - Detection of alveolar macrophage-derived IL-1β in asthma. J Immunol 1992; 149: 3078-3082.
5. Robinson DR, Hamid Q, Ying S, et al. - Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
6. Brusselle GG, Kips JC, Tavernier JH, et al. - Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994; 24: 73-80.
7. Brusselle GG, Kips JC, Joos GF, Bluethman H, Pauwels RA. - Allergen-induced airway inflammation and bronchial responsiveness in wild-type and IL-4 deficient mice. Am J Respir Cell Mol Biol 1995; 12: 254-259.
8. Coyle AJ, Le Gros G, Bertrand C, et al. - Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol 1995; 13: 54-59.
9. Schleimer RP, Sterbinsky SA, Kaiser J, et al. - IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. J Immunol 1992; 147: 1086-1092.
10. Fakuda T, Fekushima Y, Numao T, et al. - Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996; 14: 84-94.
11. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. - Role of vascular cell adhesion molecule/very late activation antigen-4 and intracellular adhesion molecule 1/lymphocyte function associated antigen, interaction in antigen-induced eosinophil and T-cell recruitment into the tissue. J Exp Med 1994; 179: 1145-1154.
12. Azzawi M, Bradley B, Jeffery PK, et al. - Identification of activated T-lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1410-1413.
13. Sanderson CJ. - Interleukin-5, eosinophils and disease. Blood 1992; 79: 3101-3109.
14. Lopez AF, Yo LB, Yang YC, et al. - Stimulation of proliferation, differentiation and function of human cells by primate interleukin-3. Proc Natl Acad Sci USA 1987; 84: 2761-2765.
15. Metcalf D, Begley CG, Johnson Gr, et al. - Biologic properties in vitro of a recombinant human granulocyte/macrophage colony-stimulating factor. Blood 1986; 67: 37-45.
16. Rothenberg ME, Owen WF, Silberstein DS, et al. - Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin-3. J Clin Invest 1988; 88: 1986-1992.
17. Lopez AF, Williamson J, Gamble JR, et al. - Recombinant human granulocyte/macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 1986; 78: 1220-1228.
18. Silberstein DS, Owen WF, Gasson JC, et al. - Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte/ macrophage colony-stimulating factor. J Immunol 1986; 137: 3290-3294.
19. Van Oosterhout AJM, Ladenius AR, Savelkoul HF, Van Ark I, Delsman KC, Nijkamp FP. - Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea-pigs. Am Rev Respir Dis 1993; 147: 548-552.
20. Iwama T, Nagai H, Suda H, Tsurvoka N, Koda A. - Effect of murine incombinant interleukin-5 on the cell population in guinea-pig airways. Br J Pharmacol 1992; 105: 19-22.
21. Van Oosterhout AJ, Fattah D, Van Ark, Hofman G, Buckley TL, Nijkamp FP. - Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J Allergy Clin Immunol 1995; 96: 104-112.
22. Tominga A, Takaki S, Koyama N, et al. - Transgenic mice expressing a B-cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J Exp Med 1991; 173: 429-437.
23. Dent LA, Strath M, Mellor AL, Sanderson CJ. - Eosinophilia in transgenic mice expressing interleukin-5. J Exp Med 1990; 172: 1425-1431.
24. Johnson GR, Gonda TJ, Metcalf, Hariharan IK, Cory S. - A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte/macrophage colony-stimulating factor. EMBO J 1989; 8: 441-148.
25. Chand N, Harrison JE, Rooney S, et al. - Anti IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea-pigs: a therapeutic approach. Eur J Pharmacol 1992; 211: 121-123.
26. Gulbenkian AR, Egan RW, Fernandez X, et al. - Interleukin-5 modulates eosinophil accumulation in allergic guinea-pig lung. Am Rev Respir Dis 1992; 146: 263-265.
27. Nakajima H, Iwamoto I, Tomoe S, et al - CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146: 374-377.
28. Kung TT, Stelts DM, Zurcher JA, et al. - Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 1995; 13: 360-365.
29. Mauser PJ, Pitman A, Witt A, et al. - Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea-pig model of asthma. Am Rev Respir Dis 1993; 148: 1623-1627.
30. Mauser PJ, Pitman AL, Fernandeze X, et al. - Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995; 152; 467-472.
31. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. - Interleukin 5 deficiency abolishes eosinophilia airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 1996; 183; 195-201.
32. Nagai H, Yamaguchi S, Inagaki N, Tsuruoka N, Hitoshi Y, Takatsu K. - Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyper-responsiveness in mice. Life Sci 1993; 53: 243-247.
33. Cony DB, Folkesson HG, Warnock ML, et al. - Interleukin-4, but not interleukin-5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183: 109-117.
34. Tsukagoski H, Sakamoto T, Xu W, Barnes PJ, Chung KF. - Effect of interleukin-1β on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol 1994; 93: 464-469.
35. Kips JC, Tavernier J, Pauwels RA. - Tumour necrosis factor (TNF) causes bronchial hyperresponsiveness in rats. Am J Respir Crit Care Med 1992; 145: 332-336.
36. Thomas PS, Yates DH, Barnes PJ. - Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152: 76-80.
37. Lukacs NW, Strieter RM, Chensue SW, Widmer M, Kunkel SL. - TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol 1995; 154: 5411-5417.
38. Watson ML, Smith D, Bourne AD, Thompson RC, Westwick J. - Cytokines contribute to airway dysfunction in antigen-challenged guinea-pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993; 8: 365-369.
39. Kips JC, Tavernier JH, Joos GF, Peleman RA. - The potential role of tumour necrosis factor-α in asthma. Clin Exp Allergy 1993; 23: 247-250.
40. Moncada S, Palmer RMJ, Higgs EA. - Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43; 109-142.
41. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA. - Identification of an inducible endothelial leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238-9242.
42. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. - Human dermal mast cells contain and release tumor necrosis factor-alpha, which induces endothelial leukocyte adhesion molecule-1. Proc Natl Acad Sci USA 1991; 88: 4220-4224.
43. Thornhill MH, Wellicome SM, Mchiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DD. - Tumor necrosis factor combines with IL-4 or IFN to selectivity enhance endothelial cell adhesion for T-cells. J Immunol 1991; 146: 592-598.
44. Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW. - Tumor necrosis factor type-α stimulates human endothelial cells to produce granulocyte/ macrophage colony-stimulating factor. Proc Natl Acad Sci 1986; 83: 7467-7471.
45. Stricter RM, Chensue SW, Basha MA, et al. - Human alveolar macrophage gene expresssion of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide and interleukin-1 beta. Am J Respir Cell Mol Biol 1990; 2: 321-326.
46. Moore KW, O'Garra A, Malefyt RW, Vicira P, Mosmann T. - Interleukin-10. Ann Rev Immunol 1993; 4: 165-190.
47. Schandené L, Alonso-Vega C, Willems F, et al. - B7/CD28 dependent IL-5 production by human resting T-cells is inhibited by IL-10. J Immunol 1994; 152: 4368-4374.
48. Zuany-Amorim C, Hailé S, Leduc D, et al. - Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95: 2644-2651.
49. Lack G, Renz H, Saloga J, et al. - Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airway function in a murine model of allergen sensitization. J Immunol 1994; 152: 2546-2554.
50. Manetti R, Parronchi P, Giudizi MG, et al. - Natural killer cell stimulatory factor (interleukin-12 (IL-12)) induces T-helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th-cells. J Exp Med 1993; 177: 1199-1204.
51. Naseer T, Leung DYM, Song Y, Martin R, Hamid Q. - Expression of IL-12 mRNA in baseline asthma and in response to steroid therapy. Am J Respir Crit Care Med 1995; 151: A701.
52. Kips JC, Brusselle GJ, Joos GF, et al. - Interleukin-12 (IL-12) inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996; 153: 535-539.